Total Payments
$986.68
2024 Payments
$532.20
Companies
19
Transactions
42
Medicare Patients
784
Medicare Billing
$91,912
Payment Breakdown by Category
Food & Beverage$963.56 (97.7%)
Education$23.12 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $963.56 | 41 | 97.7% |
| Education | $23.12 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $156.63 | 8 | $0 (2024) |
| ABBVIE INC. | $115.03 | 5 | $0 (2024) |
| PFIZER INC. | $110.71 | 6 | $0 (2024) |
| Medtronic, Inc. | $80.18 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $75.94 | 1 | $0 (2017) |
| Lilly USA, LLC | $74.43 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $70.61 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $47.88 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $41.72 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $30.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $532.20 | 26 | PFIZER INC. ($95.89) |
| 2023 | $251.61 | 12 | ABBVIE INC. ($47.60) |
| 2022 | $22.50 | 1 | Novo Nordisk Inc ($22.50) |
| 2021 | $104.43 | 2 | Medtronic, Inc. ($80.18) |
| 2017 | $75.94 | 1 | Merck Sharp & Dohme Corporation ($75.94) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Cardiovascular | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardio-renal | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: PAIN | ||||||
| 11/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardio-renal | ||||||
| 10/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Obesity | ||||||
| 10/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Obesity | ||||||
| 08/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: PAIN | ||||||
| 07/19/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Obesity | ||||||
| 06/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Inflammation | ||||||
| 05/31/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Neuroscience | ||||||
| 05/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: PAIN | ||||||
| 03/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Obesity | ||||||
| 03/01/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Diabetes Care | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $23.12 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 403 | 502 | $159,363 | $51,786 |
| 2022 | 8 | 250 | 388 | $96,316 | $28,010 |
| 2021 | 4 | 93 | 116 | $36,819 | $9,015 |
| 2020 | 2 | 38 | 66 | $14,134 | $3,102 |
Total Patients
784
Total Services
1,072
Medicare Billing
$91,912
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 170 | $56,868 | $15,077 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 78 | 115 | $53,720 | $14,801 | 27.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 26 | 26 | $10,468 | $7,341 | 70.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $15,348 | $5,812 | 37.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 45 | 45 | $9,888 | $3,616 | 36.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 24 | 24 | $2,592 | $1,808 | 69.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 28 | $1,544 | $881.16 | 57.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $1,593 | $849.69 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $2,590 | $809.82 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,752 | $789.93 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 123 | $41,146 | $10,884 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 62 | $28,962 | $7,688 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $9,983 | $3,887 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 36 | $8,476 | $2,157 | 25.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 20 | 20 | $4,395 | $1,601 | 36.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 17 | 17 | $1,797 | $1,192 | 66.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $1,053 | $520.03 | 49.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 12 | 84 | $504.00 | $80.03 | 15.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 57 | $18,987 | $4,135 | 21.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 26 | $12,020 | $3,240 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 22 | $5,180 | $1,376 | 26.6% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 11 | 11 | $632.64 | $264.44 | 41.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 34 | $8,625 | $1,892 | 21.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 32 | $5,508 | $1,210 | 22.0% |
About Dr. Walter Goebel, MD
Dr. Walter Goebel, MD is a Family Medicine healthcare provider based in Tigard, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2010. The National Provider Identifier (NPI) number assigned to this provider is 1831400126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walter Goebel, MD has received a total of $986.68 in payments from pharmaceutical and medical device companies, with $532.20 received in 2024. These payments were reported across 42 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($963.56).
As a Medicare-enrolled provider, Goebel has provided services to 784 Medicare beneficiaries, totaling 1,072 services with total Medicare billing of $91,912. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Tigard, OR
- Active Since 07/01/2010
- Last Updated 08/07/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1831400126
Products in Payments
- ProGrip (Device) $80.18
- NEXPLANON (Drug) $75.94
- NURTEC ODT (Drug) $72.14
- Wegovy (Drug) $71.81
- SPRAVATO (Drug) $70.61
- Ozempic (Drug) $64.07
- QULIPTA (Drug) $51.90
- Kerendia (Drug) $47.88
- TRELEGY ELLIPTA (Drug) $41.72
- VRAYLAR (Drug) $40.11
- PAXLOVID (Drug) $38.57
- Veozah (Drug) $30.00
- ZEPBOUND (Drug) $26.22
- JARDIANCE (Drug) $25.26
- CAPLYTA (Drug) $23.64
- BREZTRI (Drug) $23.12
- UBRELVY (Drug) $23.02
- MOUNJARO (Drug) $22.95
- ELIQUIS (Drug) $22.91
- FREESTYLE LIBRE 3 (Device) $22.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Tigard
Andrea Tremaine, Md, MD
Family Medicine — Payments: $5,229
Family Medicine $5,229
Dr. Standley Adamek, Do, DO
Family Medicine — Payments: $4,963
Family Medicine $4,963
Michael Phelps, Md, MD
Family Medicine — Payments: $4,553
Family Medicine $4,553
Mrs. Cynthia Gulick, Do, DO
Family Medicine — Payments: $3,721
Family Medicine $3,721
Stephen Babson
Family Medicine — Payments: $1,847
Family Medicine $1,847
Dr. Kristine Griess, D.o, D.O
Family Medicine — Payments: $1,159
Family Medicine $1,159